Global Obesity Surgery Devices Market size is projected to be valued $41 Billion by 2024; with a CAGR of 9.2% from 2017 to 2025. Obesity is mainly caused by increased fatty intake, reduced physical exercises, and genetic inheritance. Obesity surgery treats obesity by removing portion of the stomach or decrease in size of stomach through application of sleeve gastrectomy or gastric bands. Obesity surgeries has an advantageous effects on many medical conditions such as urinary stress incontinence, hypertension, low back pain, and sleep apnea, among others.
Increase in disposable income, increasing uptake of fast food, global obesity endemic, and increasing prevalence of childhood obesity are the factors propelling the growth of the obesity surgery devices market. Rising awareness among overweight people in developed regions about various ill effects of obesity, and increasing demand for less invasive procedures and obesity treatment might provide with several growth opportunities in the forecasted years. However, selective nature of obesity surgery and high procedural costs may hinder the growth of the market.
The global obesity surgery devices market is segmented as procedure, devices and geography. The market is segmented by procedure as Roux-en-Y gastric bypass, sleeve gastrectomy, adjustable gastric banding, biliopancreatic diversion with as duodenal switch, and others. Furthermore, devices segment is bifurcated as staples, gastric bands, gastric electrical stimulator, intragastric balloon, and others.
Based on geography, global obesity surgery devices market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated in U.S., Canada, and Mexico whereas Europe segment consist of UK, Russia, Germany, France, Italy, and others. Asia-Pacific is segmented into India, China, Japan, South Korea, and others while RoW is bifurcated into South America, Middle East, and Africa.
The key market players include Aspire Bariatrics, Inc., Spatz FGIA Inc., TransEnterix Inc., Medtronic Inc., EnteroMedics Inc., Allergan Inc., Johnson and Johnson, Cousin Biotech, Mediflex Surgical Products, and IntraPace Inc., among others.
The report covers
Scope of the Global Obesity Surgery Devices Market